The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure.
Arch Toxicol.
2023 Oct;97(10):2697-2705. doi: 10.1007/s00204-023-03577-2. Epub 2023 Aug 18. PubMed PMID:
37592049; PubMed Central PMCID:
PMC10529816.
N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer.
Pharmacogenet Genomics.
2023 Aug 1;33(6):136-137. doi: 10.1097/FPC.0000000000000500. Epub 2023 May 29. PubMed PMID:
37306342; PubMed Central PMCID:
PMC10524719.
Induction of glucose production by heterocyclic amines is dependent on N-acetyltransferase 2 genetic polymorphism in cryopreserved human hepatocytes.
Toxicol Lett.
2023 Jul 1;383:192-195. doi: 10.1016/j.toxlet.2023.07.002. Epub 2023 Jul 7. PubMed PMID:
37423373; PubMed Central PMCID:
PMC10528954.
Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
J Cancer Res Clin Oncol.
2023 Jul;149(8):5047-5060. doi: 10.1007/s00432-022-04436-w. Epub 2022 Nov 3. PubMed PMID:
36329350; PubMed Central PMCID:
PMC10193532.
Heterocyclic amines reduce insulin-induced AKT phosphorylation and induce gluconeogenic gene expression in human hepatocytes.
Arch Toxicol.
2023 Jun;97(6):1613-1626. doi: 10.1007/s00204-023-03488-2. Epub 2023 Apr 2. PubMed PMID:
37005939; PubMed Central PMCID:
PMC10192068.
Effects of dose and human N-acetyltransferase 1 genetic polymorphism in benzidine metabolism and genotoxicity.
Arch Toxicol.
2023 Jun;97(6):1765-1772. doi: 10.1007/s00204-023-03497-1. Epub 2023 Apr 25. PubMed PMID:
37097310; PubMed Central PMCID:
PMC10192036.
Effect of N-acetyltransferase 2 genetic polymorphism on 4,4'-methylenebis(2-chloroaniline)-induced genotoxicity and oxidative stress.
Arch Toxicol.
2023 Jun;97(6):1773-1781. doi: 10.1007/s00204-023-03508-1. Epub 2023 May 4. PubMed PMID:
37142755; PubMed Central PMCID:
PMC10259506.
Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders.
Front Pharmacol.
2023;14:1091976. doi: 10.3389/fphar.2023.1091976. eCollection 2023. Review. PubMed PMID:
37077812; PubMed Central PMCID:
PMC10106703.
Stable Isotope Tracing Reveals an Altered Fate of Glucose in N-Acetyltransferase 1 Knockout Breast Cancer Cells.
Genes (Basel).
2023 Mar 31;14(4). doi: 10.3390/genes14040843. PubMed PMID:
37107601; PubMed Central PMCID:
PMC10137864.
N-acetyltransferase 2 genetic polymorphism modifies genotoxic and oxidative damage from new psychoactive substances.
Arch Toxicol.
2023 Jan;97(1):189-199. doi: 10.1007/s00204-022-03383-2. Epub 2022 Sep 23. PubMed PMID:
36138126; PubMed Central PMCID:
PMC10187882.
Association between cigarette smoking and ovarian reserve among women seeking fertility care.
PLoS One.
2022;17(12):e0278998. doi: 10.1371/journal.pone.0278998. eCollection 2022. PubMed PMID:
36512605; PubMed Central PMCID:
PMC9746951.
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes.
Arch Toxicol.
2022 Dec;96(12):3257-3263. doi: 10.1007/s00204-022-03381-4. Epub 2022 Sep 16. PubMed PMID:
36112171; PubMed Central PMCID:
PMC9641657.
Dataset for proteomic analysis of arylamine N-acetyltransferase 1 knockout MDA-MB-231 breast cancer cells.
Data Brief.
2022 Dec;45:108634. doi: 10.1016/j.dib.2022.108634. eCollection 2022 Dec. PubMed PMID:
36426076; PubMed Central PMCID:
PMC9679541.
Transcriptional Regulation of Human Arylamine N-Acetyltransferase 2 Gene by Glucose and Insulin in Liver Cancer Cell Lines.
Toxicol Sci.
2022 Nov 23;190(2):158-172. doi: 10.1093/toxsci/kfac103. PubMed PMID:
36156098; PubMed Central PMCID:
PMC9702998.
Differences in β-naphthylamine metabolism and toxicity in Chinese hamster ovary cell lines transfected with human CYP1A2 and NAT2*4, NAT2*5B or NAT2*7B N-acetyltransferase 2 haplotypes.
Arch Toxicol.
2022 Nov;96(11):2999-3012. doi: 10.1007/s00204-022-03367-2. Epub 2022 Aug 30. PubMed PMID:
36040704; PubMed Central PMCID:
PMC10187863.
Acetyl coenzyme A kinetic studies on N-acetylation of environmental carcinogens by human N-acetyltransferase 1 and its NAT1*14B variant.
Front Pharmacol.
2022;13:931323. doi: 10.3389/fphar.2022.931323. eCollection 2022. PubMed PMID:
36386142; PubMed Central PMCID:
PMC9650386.
Hexavalent chromium increases the metabolism and genotoxicity of aromatic amine carcinogens 4-aminobiphenyl and β-naphthylamine in immortalized human lung epithelial cells.
Toxicol Appl Pharmacol.
2022 Aug 15;449:116095. doi: 10.1016/j.taap.2022.116095. Epub 2022 Jun 2. PubMed PMID:
35662664; PubMed Central PMCID:
PMC9382885.
Proteomic analysis of arylamine N-acetyltransferase 1 knockout breast cancer cells: Implications in immune evasion and mitochondrial biogenesis.
Toxicol Rep.
2022;9:1566-1573. doi: 10.1016/j.toxrep.2022.07.010. eCollection 2022. PubMed PMID:
36158865; PubMed Central PMCID:
PMC9500399.
Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
Mol Carcinog.
2022 May;61(5):481-493. doi: 10.1002/mc.23392. Epub 2022 Feb 8. PubMed PMID:
35133049; PubMed Central PMCID:
PMC9018511.
Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.
Toxicol Appl Pharmacol.
2022 May 1;442:115993. doi: 10.1016/j.taap.2022.115993. Epub 2022 Mar 27. PubMed PMID:
35353990; PubMed Central PMCID:
PMC9112076.
Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens.
Front Pharmacol.
2022;13:821133. doi: 10.3389/fphar.2022.821133. eCollection 2022. PubMed PMID:
35281898; PubMed Central PMCID:
PMC8914035.
560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment.
Front Pharmacol.
2022;13:820082. doi: 10.3389/fphar.2022.820082. eCollection 2022. PubMed PMID:
35273499; PubMed Central PMCID:
PMC8902414.
Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1.
Arch Toxicol.
2022 Feb;96(2):511-524. doi: 10.1007/s00204-021-03194-x. Epub 2021 Nov 16. PubMed PMID:
34783865; PubMed Central PMCID:
PMC8837702.
Arylamine N-Acetyltransferase 1 Activity is Regulated by the Protein Acetylation Status.
Front Pharmacol.
2022;13:797469. doi: 10.3389/fphar.2022.797469. eCollection 2022. PubMed PMID:
35153780; PubMed Central PMCID:
PMC8828969.
Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2.
Front Pharmacol.
2021;12:803254. doi: 10.3389/fphar.2021.803254. eCollection 2021. PubMed PMID:
35046826; PubMed Central PMCID:
PMC8762260.
Arylamine N-acetyltransferase acetylation polymorphisms: paradigm for pharmacogenomic-guided therapy- a focused review.
Expert Opin Drug Metab Toxicol.
2021 Jan;17(1):9-21. doi: 10.1080/17425255.2021.1840551. Epub 2020 Nov 3. Review. PubMed PMID:
33094670; PubMed Central PMCID:
PMC7790970.
Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes.
Arch Toxicol.
2021 Jan;95(1):311-319. doi: 10.1007/s00204-020-02901-4. Epub 2020 Nov 2. PubMed PMID:
33136180; PubMed Central PMCID:
PMC7855884.
Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2.
Toxicol Rep.
2020;7:1319-1330. doi: 10.1016/j.toxrep.2020.09.011. eCollection 2020. PubMed PMID:
33083237; PubMed Central PMCID:
PMC7553889.
CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
Sci Rep.
2020 Jun 17;10(1):9804. doi: 10.1038/s41598-020-66863-4. PubMed PMID:
32555504; PubMed Central PMCID:
PMC7299936.
Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes.
Sci Rep.
2020 May 5;10(1):7566. doi: 10.1038/s41598-020-64508-0. PubMed PMID:
32372066; PubMed Central PMCID:
PMC7200704.
N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes.
Pharmacogenet Genomics.
2020 Apr;30(3):61-65. doi: 10.1097/FPC.0000000000000394. PubMed PMID:
31895247; PubMed Central PMCID:
PMC7060095.
Role of Human N-Acetyltransferase 2 Genetic Polymorphism on Aromatic Amine Carcinogen-Induced DNA Damage and Mutagenicity in a Chinese Hamster Ovary Cell Mutation Assay.
Environ Mol Mutagen.
2020 Feb;61(2):235-245. doi: 10.1002/em.22331. Epub 2019 Sep 30. PubMed PMID:
31490564; PubMed Central PMCID:
PMC7017392.
N-Acetyltransferase 1 Knockout Elevates Acetyl Coenzyme A Levels and Reduces Anchorage-Independent Growth in Human Breast Cancer Cell Lines.
J Oncol.
2019;2019:3860426. doi: 10.1155/2019/3860426. eCollection 2019. PubMed PMID:
31531019; PubMed Central PMCID:
PMC6720663.
Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianiline.
Arch Toxicol.
2019 Aug;93(8):2237-2246. doi: 10.1007/s00204-019-02516-4. Epub 2019 Jul 10. PubMed PMID:
31292670; PubMed Central PMCID:
PMC6713601.
Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
Mol Carcinog.
2018 Nov;57(11):1458-1466. doi: 10.1002/mc.22869. Epub 2018 Jul 18. PubMed PMID:
29964355; PubMed Central PMCID:
PMC6353662.
Functional expression of human arylamine N-acetyltransferase NAT1*10 and NAT1*11 alleles: a mini review.
Pharmacogenet Genomics.
2018 Oct;28(10):238-244. doi: 10.1097/FPC.0000000000000350. Review. PubMed PMID:
30222709; PubMed Central PMCID:
PMC6208141.
Expression and genotype-dependent catalytic activity of N-acetyltransferase 2 (NAT2) in human peripheral blood mononuclear cells and its modulation by Sirtuin 1.
Biochem Pharmacol.
2018 Oct;156:340-347. doi: 10.1016/j.bcp.2018.08.034. Epub 2018 Aug 25. PubMed PMID:
30149019; PubMed Central PMCID:
PMC6350916.
Retrospective analysis of estrogen receptor 1 and N‑acetyltransferase gene expression in normal breast tissue, primary breast tumors, and established breast cancer cell lines.
Int J Oncol.
2018 Aug;53(2):694-702. doi: 10.3892/ijo.2018.4436. Epub 2018 Jun 11. PubMed PMID:
29901116; PubMed Central PMCID:
PMC6017241.
In Memoriam: Wendell W. Weber, PhD, MD (1925-2018).
Pharmacogenet Genomics. 2018 July; 28(7):177-178. NIHMSID: NIHMS966857.doi: 10.1097/FPC.0000000000000340.
Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
Mol Carcinog.
2018 Apr;57(4):549-558. doi: 10.1002/mc.22779. Epub 2018 Feb 3. PubMed PMID:
29315819; PubMed Central PMCID:
PMC5832614.
Design and Success of a 21st Century Cancer Education Program at the University of Louisville.
J Cancer Educ.
2018 Apr;33(2):298-308. doi: 10.1007/s13187-016-1083-5. PubMed PMID:
27474114; PubMed Central PMCID:
PMC5280580.
High N-Acetyltransferase 1 Expression Is Associated with Estrogen Receptor Expression in Breast Tumors, but Is not Under Direct Regulation by Estradiol, 5α-androstane-3β,17β-Diol, or Dihydrotestosterone in Breast Cancer Cells.
J Pharmacol Exp Ther.
2018 Apr;365(1):84-93. doi: 10.1124/jpet.117.247031. Epub 2018 Jan 16. PubMed PMID:
29339455; PubMed Central PMCID:
PMC5830641.
Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype.
Arch Toxicol.
2018 Feb;92(2):661-668. doi: 10.1007/s00204-017-2082-y. Epub 2017 Oct 17. PubMed PMID:
29043425.
Role of N-acetyltransferase 2 acetylation polymorphism in 4, 4'-methylene bis (2-chloroaniline) biotransformation.
Toxicol Lett.
2018 Feb;283:100-105. doi: 10.1016/j.toxlet.2017.11.028. Epub 2017 Nov 24. PubMed PMID:
29180287; PubMed Central PMCID:
PMC5745265.
The human arylamine N-acetyltransferase type 2 gene: Genomics and cardiometabolic risk.
In:
Laurieri N, Sim E, editors.
Arylamine N-Acetyltransferases in Health and Disease
[Internet]
Singapore: World Scientific Publishing; 2018. Chapter 1.2; p.43-67.
Available from: https://www.worldscientific.com/doi/10.1142/9789813232013_0002.
N-acetyltransferase 2 polymorphism and human urinary bladder and breast cancer risks.
In:
Laurieri N, Sim E, editors.
Arylamine N-Acetyltransferases in Health and Disease
[Internet]
Singapore: World Scientific Publishing; 2018. Chapter 4.1; p.327-349.
Available from: https://www.worldscientific.com/doi/abs/10.1142/9789813232013_0013.
N-Acetyltransferase 2 Genotype-Dependent N-Acetylation of Hydralazine in Human Hepatocytes.
Drug Metab Dispos.
2017 Dec;45(12):1276-1281. doi: 10.1124/dmd.117.078543. Epub 2017 Oct 10. PubMed PMID:
29018032; PubMed Central PMCID:
PMC5706087.
Rabbit N-acetyltransferase 2 genotyping method to investigate role of acetylation polymorphism on N- and O-acetylation of aromatic and heterocyclic amine carcinogens.
Arch Toxicol.
2017 Sep;91(9):3185-3188. doi: 10.1007/s00204-017-1997-7. Epub 2017 May 23. PubMed PMID:
28536864; PubMed Central PMCID:
PMC5700865.
Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype.
Arch Toxicol.
2017 Aug;91(8):2827-2835. doi: 10.1007/s00204-017-1989-7. Epub 2017 May 18. PubMed PMID:
28523442; PubMed Central PMCID:
PMC5710007.
Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
Arch Toxicol.
2017 Jul;91(7):2655-2661. doi: 10.1007/s00204-017-1988-8. Epub 2017 May 17. PubMed PMID:
28516247; PubMed Central PMCID:
PMC5713641.
What would you like to do?